31st May 2019 15:32
LONDON (Alliance News) - Motif Bio PLC on Friday said that shareholders voted against approval of the company's remuneration report.
At the clinical-stage biopharmaceutical firm's annual general meeting, held earlier on Friday, all other resolutions were passed.
"The board is committed to remaining aligned with shareholder interests through its remuneration structures which are in place to recruit and retain talent," Motif Bio said.
Motif Bio shares were trading 3.0% lower at 8.50 pence each.
Related Shares:
MTFB.L